Filing Details

Accession Number:
0001209191-15-022917
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-05 16:11:01
Reporting Period:
2015-03-03
Filing Date:
2015-03-05
Accepted Time:
2015-03-05 16:11:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI Services-Medical Laboratories (8071) 271316416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1584999 A. Vincent Miller 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-03 14,058 $0.84 113,120 No 4 M Direct
Common Stock Acquisiton 2015-03-03 3,000 $0.84 116,120 No 4 M Direct
Common Stock Disposition 2015-03-03 17,058 $47.81 99,062 No 4 S Direct
Common Stock Acquisiton 2015-03-03 4,813 $0.84 103,875 No 4 M Direct
Common Stock Acquisiton 2015-03-03 5,467 $4.16 109,342 No 4 M Direct
Common Stock Acquisiton 2015-03-03 3,125 $7.12 112,467 No 4 M Direct
Common Stock Acquisiton 2015-03-03 2,348 $29.94 114,815 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Disposition 2015-03-03 14,058 $0.00 14,058 $0.84
Common Stock stock option (right to buy) Disposition 2015-03-03 7,813 $0.00 7,813 $0.84
Common Stock stock option (right to buy) Disposition 2015-03-03 5,467 $0.00 5,467 $4.16
Common Stock stock option (right to buy) Disposition 2015-03-03 3,125 $0.00 3,125 $7.12
Common Stock stock option (right to buy) Disposition 2015-03-03 2,348 $0.00 2,348 $29.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,942 2022-01-10 No 4 M Direct
17,187 2022-01-10 No 4 M Direct
7,033 2023-03-07 No 4 M Direct
9,375 2023-05-21 No 4 M Direct
8,381 2024-04-09 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected to cover the tax liabilities of the reporting person in connection with the exercise of the stock options referenced herein. The reporting person exercised such stock options in order to participate in the tender offer commenced by Roche Holdings, Inc. on February 2, 2015.
  2. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.75 to $48.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  3. This option was granted on January 10, 2012 and vests in equal quarterly installments beginning on December 31, 2012 until fully vested on September 30, 2016.
  4. This option was granted on January 10, 2012 and vests in equal quarterly installments beginning on December 31, 2013 until fully vested on September 30, 2017.
  5. This option was granted on March 7, 2013 and vests in equal quarterly installments beginning June 7, 2013 until fully vested on March 7, 2017.
  6. This option was granted on May 21, 2013 and vests in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018.
  7. This option was granted on April 9, 2014 and vests in equal quarterly installments beginning June 30, 2014 until fully vested on March 31, 2018.